Low-Dose Tamoxifen Was Safe and Effective at Reducing Recurrence and New Breast Disease for Patients With DCIS, LCIS, and ADH
Circulating Tumor Cell Count Could Help Choose Treatment for Metastatic Breast Cancer Patients
Axillary Radiotherapy and Lymph Node Surgery Yielded Comparable 10-year Outcomes for Patients with Breast Cancer
Accelerated Partial Breast Irradiation, Although Close, was Not Equivalent to Whole Breast Irradiation To Control Ipsilateral Breast Tumor Recurrence
ATI-450 – pancreatic cancer.
darolutamide – metastatic hormone sensitive prostate cancer.
mirvetuximab soravtansine – in ovarian cancer.
KB-0742 – in MYC-amplified solid tumors.
zandelisib – in relapsed/refractory follicular lymphoma.
OP-1250 – in ≥4-line ER+/HER2-negative breast cancer.
Compendium (d) Compendium (f)